Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer
Clinical trial NCT07756593 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07756593
- Sponsor
- Washington University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-30
- Primary completion
- 2029-04-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.